IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding IGC Pharma, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 29 | 29 | 0 |
| Shares | 6.22M | 4.18M | −2.04M (−32.8%) |
| Value | $6.07M | $3.97M | −$2.11M (−34.7%) |
New holders (3)
Institutions that held IGC Pharma, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Group One Trading, L.P. | 26,798 | $25.0K | 0.00% |
| Two Sigma Securities, LLC | 14,436 | $14.0K | 0.00% |
| Fairfield Financial Advisors, LTD | 500 | $474 | 0.00% |
Sold out (3)
Institutions that held IGC Pharma, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Bank of America Corp | 90,320 | $88.0K |
| Wolverine Trading, LLC | 12,462 | $12.0K |
| FNY Investment Advisers, LLC | 12,000 | $11.0K |